Evidence mapPaperPMID 41599364Full record

ArticleMolecules (Basel, Switzerland)2026

Xiaoying Sun, Kangxu He, Guanzhong Chen, Xiaoda Yang, Xinhui Pan, Kai Liao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoying SunKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Institute for Safflower Industry Research, School of Pharmacy, Shihezi University, Shihezi 832002, China.ORCID 0000-0002-9494-3637
Kangxu HeKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Institute for Safflower Industry Research, School of Pharmacy, Shihezi University, Shihezi 832002, China.
Guanzhong ChenKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Institute for Safflower Industry Research, School of Pharmacy, Shihezi University, Shihezi 832002, China.
Xiaoda YangStake Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Xinhui PanKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Institute for Safflower Industry Research, School of Pharmacy, Shihezi University, Shihezi 832002, China.
Kai LiaoKey Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Institute for Safflower Industry Research, School of Pharmacy, Shihezi University, Shihezi 832002, China.ORCID 0009-0004-2658-7003

Funding

National Natural Science Foundation of China 82160651
6 · The paper itself

Abstract

Contrast-induced acute kidney injury (CIAKI) has emerged as the third most prevalent etiology of clinically acquired acute kidney injury, with a lack of specific preventive and therapeutic strategies.

Indexed as

Acute Kidney InjuryAutophagyContrast MediaMethylene ChlorideMicrotubule-Associated ProteinsPlant ExtractsRubiaAnimalsApoptosisMaleMolecular Docking SimulationOxidative StressRatsAnxa3 protein, ratContrast MediaMethylene ChlorideMicrotubule-Associated ProteinsPlant Extractsapoptosisautophagiccontrast-induced acute kidney injurydichloromethane extractLC3B/p62Rubia cordifolia L.

Identifiers

PMID41599364
PMCPMC12844358

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.